Aerin Medical today touted one-year results from a trial evaluating the safety and efficacy of its RhinAer system in those with chronic rhinitis. Sunnyvale, Calif.–based Aerin designed RhinAer as a temperature-controlled radiofrequency technology used to disrupt nerve signals that cause chronic rhinitis symptoms. According to a news release, the study demonstrated that, following a single […]
Otolaryngology/Ear, Nose & Throat (ENT)
FDA clears Boston Scientific’s Exalt Model B single-use bronchoscope
Boston Scientific (NYSE:BSX) announced today that it received FDA 510(k) clearance for its Exalt Model B single-use bronchoscope. Marlborough, Mass.-based Boston Scientific designed the Exalt Model B for use in bedside procedures within the intensive care unit and operating room, according to a news release. Uses for the device include a wide range of bronchoscopy […]
Aerin Medical touts study of nasal airway obstruction treatment
Aerin Medical today touted results from a three-month study of its VivAer treatment for nasal airway obstruction (NAO). Sunnyvale, Calif.-based Aerin’s VivAer was studied in the VATRAC trial, with results published by the International Forum of Allergy and Rhinology. According to a news release, the study confirmed the safety and efficacy of VivAer in treating […]
FDA approves Oticon Medical’s Neuro cochlear implant system
Oticon Medical today said the FDA has granted premarket approval for the company’s Neuro Cochlear Implant System. Somerset, N.J.-based Oticon Medical designed the Neuro system to treat people 18 years or older with bilateral severe-to-profound sensorineural hearing loss and who have limited benefits from fitted hearing aids. “At Oticon Medical, we are passionate about using […]
Preceptis Medical launches tympanostomy tube system for in-office pediatric ear tube procedures
Preceptis Medical today said it has launched its Hummingbird tympanostomy tube system for office-based pediatric ear tube procedures. The Maple Grove, Minn.–based company designed the device with an ergonomic design to allow for more efficient ear tube delivery in children. Get the full story on our sister site, Medical Tubing + Extrusion.
GM Instruments, Sensonics partner on nasal and oral measurement devices
GM Instruments announced today that it partnered with Sensonics to develop devices for the quantitative assessment of nasal and oral function. The companies tout the first-of-its-kind partnership as a bringing together of sensory and engineering expertise for evaluating and treating nasal and oral diseases. Get the full story at our sister site, Drug Delivery Business News.
Lyra inks $135M partnership to expand chronic rhinosinusitis treatment in Asia
Lyra Therapeutics (NSDQ:LYRA) announced today that it entered into a strategic partnership with LianBio for its LYR-210 treatment for chronic rhinosinusitis. Watertown, Mass.–based Lyra, which develops the LYR-210 therapeutic to be locally delivered by its proprietary XTreo platform, could receive up to $135 million in total payments through the strategic partnership and exclusive license agreement […]
Noveome Biotherapeutics inks licensing deal for SipNose drug delivery device
Noveome Biotherapeutics announced that it entered a commercial license agreement to use SipNose’s proprietary drug delivery device. Yokneam, Israel–based SipNose develops its intranasal Cribriform Targeted Device (CT6), which, under the agreement, was licensed to Noveome to deliver the Pittsburgh-based company’s ST266 biologic to the central nervous systems, according to a news release. Get the full story at our […]
Intersect ENT wins CE mark for Propel Contour sinus implant
Intersect ENT (NSDQ:XENT) announced today that it received CE mark approval for its Propel Contour sinus implant. Menlo Park, Calif.-based Intersect ENT designed its Propel Contour sinus implant to maintain patency and reduce inflammation while conforming to the sinus ostia (openings) through mechanical support and steroid delivery where needed to optimize sinus surgery outcomes. Propel […]
Lyra Therapeutics rises on Q1 earnings
Lyra Therapeutics (NSDQ:LYRA) shares finished up on the day despite first-quarter results that missed the consensus earnings forecast. The Watertown, Mass.-based chronic rhinosinusitis (CRS) treatment developer posted losses of -$7.8 million, or -60¢ per share for the three months ended March 31, 2021, for a -84.4% bottom-line slide. Lyra’s EPS of -60¢ came in 48¢ behind […]
Intersect ENT appoints VP of sales
Intersect ENT (NSDQ:XENT) today said it has appointed Mark Alley as VP of sales, effective May 10. Alley most recently served as chief commercial officer at Levita Magnetics. He has more than 20 years of commercial and sales experience and has held numerous leadership roles at Stryker ENT, Spirox and Acclarent. “Mark has a reputation for […]